Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

OncoSec Medical Incorporated (ONCS)

2.24   0.03 (1.36%) 12-06 16:00
Open: 2.22 Pre. Close: 2.21
High: 2.2664 Low: 2.22
Volume: 104,980 Market Cap: 24M
OncoSec Medical Inc is a biotechnology company engaged in designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.273 - 2.281 2.281 - 2.288
Low: 2.197 - 2.208 2.208 - 2.216
Close: 2.224 - 2.24 2.24 - 2.254

Technical analysis

as of: 2019-12-06 4:37:14 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.86     One year: 3.34
Support: Support1: 2.05    Support2: 1.80
Resistance: Resistance1: 2.45    Resistance2: 2.86
Pivot: 2.06
Moving Average: MA(5): 2.18     MA(20): 2.06
MA(100): 2.08     MA(250): 3.94
MACD: MACD(12,26): 0.02     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 90.15     %D(3): 87.95
RSI: RSI(14): 59.54
52-week: High: 9.50  Low: 1.60  Change(%): -74.5
Average Vol(K): 3-Month: 27638  10-Days: 6125

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ONCS has closed below upper band by 6.7%. Bollinger Bands are 11.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

OncoSec Comments on Disturbing Elements of Alpha Holdings’ Revised Preliminary Proxy Filing
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)--OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, issued a statement highlighting a troubling voting scheme buried in Alpha Holdings, Inc.’s (“Alpha”) revised preliminary proxy statement filed on December 3, 2019. The relevant section is below: If we obtain a sufficient number of votes AGAINST the proposal being submitted at the Special Meeting for stockhol

OncoSec Sets the Record Straight on Alpha Holdings’ False and Misleading Statements
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)--OncoSec Medical Incorporated (NASDAQ: ONCS), (the “Company” or “OncoSec”) a company developing late-stage intratumoral cancer immunotherapies, today issued the following letter to shareholders. The full text of the letter and additional information can be found at December 2, 2019 Dear Fellow OncoSec Shareholders, OncoSec Medical Incorporated (“OncoSec”, the “Company”, “we” or “our”) has scheduled a Special Meeting of Shar

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 10.67
Shares Float (M) 7.44
% Held by Insiders 18.21
% Held by Institutions 6.40
Shares Short (K) 245
Shares Short P. Month (K)

Stock Financials

EPS -4.292
Book Value (p.s.) 2.280
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -62.4
Return on Equity (ttm) -128.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.790
Qtrly Earnings Growth
Operating Cash Flow (M) -29.00
Levered Free Cash Flow (M) -16.86

Stock Valuations

P/E -0.52
P/E Growth Ratio 0.01
P/BV 0.98
P/CF -0.82

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-05-21
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.